|
Re: citi LoC
|
3
|
Resverlogix Corp.
|
Feb 05, 2017 02:14PM
|
|
Re: citi LoC
|
2
|
Resverlogix Corp.
|
Feb 05, 2017 04:35PM
|
|
Re: Gasoline
|
3
|
Zenith Epigenetics
|
Feb 05, 2017 08:21PM
|
|
Re: Zenith BIO CEO & Investor Conference 2017 Slides
|
1
|
Zenith Epigenetics
|
Feb 15, 2017 10:54AM
|
|
Re: Zenith BIO CEO & Investor Conference 2017 Slides
|
1
|
Zenith Epigenetics
|
Feb 15, 2017 04:54PM
|
|
Re: Article in Nature - An epigenetics gold rush: new controls for gene expression
|
4
|
Resverlogix Corp.
|
Feb 23, 2017 02:57AM
|
|
Re: That's a Strong P Value....
|
5
|
Resverlogix Corp.
|
Feb 23, 2017 01:38PM
|
|
Re: BET inhibitors promising therapy for rare pediatric brain tumor
|
4
|
Zenith Epigenetics
|
Feb 28, 2017 06:03PM
|
|
Broker Meeting 23 Feb
|
13
|
Resverlogix Corp.
|
Feb 28, 2017 08:40PM
|
|
Broker Meeting 23 Feb
|
6
|
Zenith Epigenetics
|
Feb 28, 2017 09:05PM
|
|
Re: Broker Meeting 23 Feb
|
3
|
Resverlogix Corp.
|
Mar 01, 2017 12:12AM
|
|
Re: Broker Meeting 23 Feb
|
3
|
Resverlogix Corp.
|
Mar 01, 2017 12:26AM
|
|
Re: Broker Meeting 23 Feb
|
4
|
Resverlogix Corp.
|
Mar 01, 2017 02:28AM
|
|
Re: Broker Meeting 23 Feb
|
3
|
Resverlogix Corp.
|
Mar 01, 2017 09:45AM
|
|
Re: Broker Meeting 23 Feb
|
4
|
Resverlogix Corp.
|
Mar 01, 2017 11:00AM
|
|
Re: Broker Meeting 23 Feb
|
2
|
Resverlogix Corp.
|
Mar 01, 2017 11:59AM
|
|
Re: Broker Meeting 23 Feb
|
3
|
Zenith Epigenetics
|
Mar 01, 2017 12:50PM
|
|
Re: Broker Meeting 23 Feb
|
1
|
Resverlogix Corp.
|
Mar 01, 2017 01:39PM
|
|
Re: Broker Meeting 23 Feb
|
2
|
Resverlogix Corp.
|
Mar 01, 2017 03:01PM
|
|
Re: Slow Response Here Too!
|
3
|
Zenith Epigenetics
|
Mar 01, 2017 05:50PM
|
